Ionis Pharmaceuticals, Inc. (IONS)
60.35
-0.70
(-1.15%)
USD |
NASDAQ |
Aug 31, 16:00
60.35
0.00 (0.00%)
After-Hours: 20:00
Ionis Pharmaceuticals Cash from Operations (TTM) : -496.43M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -496.43M |
| March 31, 2026 | -910.63M |
| December 31, 2025 | -268.58M |
| September 30, 2025 | -247.01M |
| June 30, 2025 | -230.57M |
| March 31, 2025 | -501.78M |
| December 31, 2024 | -500.95M |
| September 30, 2024 | -351.94M |
| June 30, 2024 | -345.98M |
| March 31, 2024 | -323.46M |
| December 31, 2023 | -307.51M |
| September 30, 2023 | -540.57M |
| June 30, 2023 | -455.98M |
| March 31, 2023 | -376.71M |
| December 31, 2022 | -274.37M |
| September 30, 2022 | 129.51M |
| June 30, 2022 | 98.37M |
| March 31, 2022 | 53.81M |
| December 31, 2021 | 30.80M |
| September 30, 2021 | -74.91M |
| June 30, 2021 | -29.61M |
| March 31, 2021 | -11.18M |
| December 31, 2020 | 35.89M |
| September 30, 2020 | 215.85M |
| June 30, 2020 | 213.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 230.42M |
| December 31, 2019 | 345.72M |
| September 30, 2019 | 183.28M |
| June 30, 2019 | 170.08M |
| March 31, 2019 | 697.43M |
| December 31, 2018 | 602.89M |
| September 30, 2018 | 507.80M |
| June 30, 2018 | 562.52M |
| March 31, 2018 | 64.65M |
| December 31, 2017 | 174.15M |
| September 30, 2017 | 127.79M |
| June 30, 2017 | 122.48M |
| March 31, 2017 | 86.33M |
| December 31, 2016 | -112.10M |
| September 30, 2016 | -123.62M |
| June 30, 2016 | -110.81M |
| March 31, 2016 | -11.82M |
| December 31, 2015 | 21.12M |
| September 30, 2015 | 129.28M |
| June 30, 2015 | 95.01M |
| March 31, 2015 | -4.213M |
| December 31, 2014 | 6.285M |
| September 30, 2014 | -78.89M |
| June 30, 2014 | -15.01M |
| March 31, 2014 | 41.74M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 885.89M |
| Biogen, Inc. | 2.879B |
| BridgeBio Pharma, Inc. | -434.37M |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |